Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for November 8th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 8th:

CyberOptics Corporation (CYBE - Free Report) : This high precision sensing technology developing company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

CyberOptics’ shares gained nearly 30% over the last one month above the S&P 500’s increase 6.6%. The company possesses a Momentum Score of A.

EverQuote, Inc. (EVER - Free Report) : This online marketplace for insurance shopping has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 37% over the last 60 days.

EverQuote’s shares gained 52.8% over the last one month. The company possesses a Momentum Score of A.

InMode Ltd. (INMD - Free Report) : This minimally-invasive aesthetic medical products development company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 12.3% over the last 60 days.

InMode Ltd. Price and Consensus

InMode Ltd. Price and Consensus

InMode Ltd. price-consensus-chart | InMode Ltd. Quote

InMode’s shares gained 80.9% over the last one month. The company possesses a Momentum Score of A.

Moderna, Inc. (MRNA - Free Report) : This clinical stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Moderna’s shares gained 14.3% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Moderna, Inc. (MRNA) - free report >>

InMode Ltd. (INMD) - free report >>

EverQuote, Inc. (EVER) - free report >>

CyberOptics Corporation (CYBE) - free report >>

Published in